Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01905
Species: Homo sapiens
Position : chr16:15600300-15601300
Year: 2014
Title: Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  23698277
MONDO: MONDO:0008315
Tissue: Prostate
Tissue Ontology ID: UBERON:0002367
Cell Source: VCaP
CVCL ID: CVCL_2235
Cell Type: prostate carcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: 4C-seq, ChIP-seq
Low Throughput Method: Luciferase reporter assay, ChIP-RT-qPCR, 3C, RT-RT-qPCR, shRNA knockdown, Western blot
About Target Gene
Target gene : TAL1
About TF
TF name : MAF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MAF AP-1 transcription factor network pid 71
MAF C-MYB transcription factor network pid 87
MAF Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
MAF Kaposi sarcoma-associated herpesvirus mirtarbase 13
MAF Hs_TYROBP_Causal_Network_WP3945_90843 wikipathways 54
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer